Sethera Therapeutics, Inc — Form D

Sethera Therapeutics, Inc of SALT LAKE CITY, UT, a company, filed a Form D exempt-offering notice with the SEC on 2024-10-30. The offering totals $3.0M, of which $1.9M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2024-10-30
• Form: D
• Accession: 0002042692-24-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $3.0M
• Amount sold: $1.9M
• Remaining: $1.1M
• Investors: 21
• Date of first sale: 2024-10-15
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-528211

Issuer

• Name: Sethera Therapeutics, Inc
• CIK: 0002042692
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2024
• Address: 48 SOUTH RIO GRANDE STREET, SALT LAKE CITY, UT, 84101
• Phone: 801-850-4367

Officers, directors & promoters (7)

More

• CIK 2042692 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search